Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 94625933 | 9462593 | 3 | F | 20160711 | 20130816 | 20160713 | EXP | ZA-BRISTOL-MYERS SQUIBB COMPANY-19180645 | BRISTOL MYERS SQUIBB | 34.00 | YR | F | Y | 0.00000 | 20160713 | OT | ZA | ZA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 94625933 | 9462593 | 1 | PS | EFAVIRENZ | EFAVIRENZ | 1 | Oral | UNK | Y | 20972 | CAPSULE | ||||||||
| 94625933 | 9462593 | 2 | SS | STAVUDINE. | STAVUDINE | 1 | Unknown | UNK | Y | 0 | |||||||||
| 94625933 | 9462593 | 3 | SS | LAMIVUDINE. | LAMIVUDINE | 1 | Unknown | UNK | Y | 0 | |||||||||
| 94625933 | 9462593 | 4 | SS | NEVIRAPINE. | NEVIRAPINE | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 94625933 | 9462593 | 1 | HIV infection |
| 94625933 | 9462593 | 2 | HIV infection |
| 94625933 | 9462593 | 3 | HIV infection |
| 94625933 | 9462593 | 4 | HIV infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 94625933 | 9462593 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 94625933 | 9462593 | Abortion induced | |
| 94625933 | 9462593 | Maternal exposure during pregnancy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |